Mr. Pei Yang | Brain Glioma | Best Researcher Award

• Mr. Pei Yang embarked on an illustrious academic career in medicine, beginning with a Bachelor’s degree in Clinical Medicine from Chengde Medical College (2005–2010). She further honed her expertise with a Master’s and PhD in Neurosurgery at Capital Medical University (2010–2016). Her rigorous training laid a strong foundation for her future contributions to neurosurgery and glioma research.

 🏥 Professional Milestones:

• Since joining the Beijing Neurosurgery Institute, Mr. Yang has steadily progressed, currently serving as an Associate Chief Physician (2022–present). Her prior roles as an Attending Physician (2019–2021) and Physician (2016–2018) reflect her relentless pursuit of excellence in patient care and medical innovation. Her work focuses on glioma pathology and neurosurgical advancements, positively impacting patients and the field alike.

🧬 Research Contributions:

• Mr. Yang’s research is at the cutting edge of understanding brain tumors, particularly gliomas. Her work delves into mechanisms such as the c-MET/E2F1/DMC1 signaling pathway and its role in chemotherapy resistance. Notably, she has successfully completed a National Natural Science Foundation of China project investigating this pathway’s impact on DNA repair. Additionally, her ongoing project on terahertz time-domain spectroscopy in glioma diagnosis highlights her innovative approach to integrating technology with medicine.

📜 Academic Publications:

• Mr. Yang has authored numerous impactful publications in esteemed journals. Among her key works are:
  • A study on a nine-gene signature in gliomas (Clinical Immunology, 2020), where she served as a co-corresponding author.
  • Research into the immunosuppressive roles of VAT1 expression in diffuse gliomas (Cancer Immunology, Immunotherapy, 2021), for which she was the sole first author.
  • Investigations into terahertz spectral applications in glioma pathology (Spectrochimica Acta Part A, 2023), emphasizing her role as a co-corresponding author.

  These publications highlight her ability to translate complex findings into meaningful contributions for both academia and clinical practice.

🌟 Vision for the Future: 

• With ongoing projects exploring cutting-edge methodologies, such as terahertz spectroscopy and the prediction of glioma mutations, Mr. Yang is determined to revolutionize glioma diagnostics and treatment. Her dedication to neurosurgical research, combined with a passion for patient care, positions her as a trailblazer in the field.

🏅 Recognitions and Beyond:

• Though not yet formally awarded for her academic and clinical achievements, Mr. Yang’s influence is evident through her leadership roles in pioneering research and her commitment to nurturing the next generation of medical professionals.